Top 10 Medical Innovations according to the Cleveland Clinic (10)
An experimental drug – an inhibitor of angiotensin receptors and the enzyme neprilysin – reduces the incidence of death from cardiovascular diseases and hospitalization due to heart failure by 20% compared to the results of traditional therapy.
11.12.2014